Question follow-through · 91024

NHS: Negligence

To ask the Secretary of State for Health and Social Care, to provide a breakdown of (a) total pay-outs (b) total value of claims to category A patients by (i) UK citizens (ii) asylum seekers for the financial year 24/25.

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
13 Nov 2025
Target answer date
19 Nov 2025
Answer
26 Nov 2025 · 13 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 13 Nov 2025

    Question tabled

    To ask the Secretary of State for Health and Social Care, to provide a breakdown of (a) total pay-outs (b) total value of claims to category A patients by (i) UK citizens (ii) asylum seekers for the financial year 24/25.

  2. 19 Nov 2025

    Target answer date

    Date supplied by the official written-questions record.

  3. 26 Nov 2025

    Answer published

    NHS Resolution manages clinical negligence and other claims against the National Health Service in England. This data is not held by NHS Resolution.

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

NHS: Disclosure of Information

14 Nov 2025 · To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of establishing a dedicated whistleblowing line for NHS staff and patients to report issues with language barriers in the National Health Servi

Unreviewed candidateSame MP and department; topic relationship is unreviewed

NHS: Migrant Workers

17 Nov 2025 · To ask the Secretary of State for Health and Social Care, what proportion of internationally recruited NHS workers were required to retake the International English Language Testing System more than once to meet employment eligibility criteria between 202

Unreviewed candidateSame MP and department; topic relationship is unreviewed

NHS: Migrant Workers

17 Nov 2025 · To ask the Secretary of State for Health and Social Care, what the average International English Language Testing System scores were for internationally recruited healthcare professionals entering the NHS via the international recruitment programme in eac

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Health Professions: Migrant Workers

17 Nov 2025 · To ask the Secretary of State for Health and Social Care, how many and what proportion of (i) nurses (ii) doctors (iii) midwives entering the NHS were (a) non-UK citizens (b) non-UK graduates in each of the last five years.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Medical Treatments: Gaza

19 Nov 2025 · To ask the Secretary of State for Health and Social Care, pursuant to the answer of 17 November 2025 to question 81592 on Medical Treatments: Gaza, what the estimated total cost of the programme will be to the public purse.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Puberty Suppressing Hormones: Children

24 Nov 2025 · To ask the Secretary of State for Health and Social Care, how many children under the age of 16 were administered puberty blockers, including through (a) clinical trials and (b) private routes in each of the last five years; and what adverse effects were

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Puberty Suppressing Hormones: Children

24 Nov 2025 · To ask the Secretary of State for Health and Social Care, whether he has obtained legal advice on whether putting minors on puberty blockers constitutes a breach of child-safeguarding duties.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Puberty Suppressing Hormones

24 Nov 2025 · To ask the Secretary of State for Health and Social Care, what information his Department holds on the number of de-transitioners reporting harm from puberty blockers; and whether his Department considered this data as part of its approval of the trial.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Puberty Suppressing Hormones: Children

24 Nov 2025 · To ask the Secretary of State for Health and Social Care, what guidance his Department has issued on the capacity of children aged between 11 and 15 to consent to medical trials related to puberty blockers.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Puberty Suppressing Hormones

24 Nov 2025 · To ask the Secretary of State for Health and Social Care, if he will hold discussions with Kings College London on the potential merits of pausing recruitment to the new Pathway puberty-blocker trial until an independent panel considers the findings of th

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Puberty Suppressing Hormones: Civil Proceedings

24 Nov 2025 · To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential impact of the Pathway puberty-blocker trial on future legal claims by participants.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Puberty Suppressing Hormones: Advocacy

24 Nov 2025 · To ask the Secretary of State for Health and Social Care, whether his Department consulted (a) Stonewall, (b) Mermaids and (c) other advocacy organisations at any stage during the (i) design, (ii) approval, and (iii) communication of the PATHWAYS trial.